Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis

Hepatology

Volumn 26, Issue 3, 1997, Pages 664-669

  Maria, Vasco A J ^a,b   Victorino, Rui M M ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0030865914     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260319     Document Type: Article

References (28)

1. Miller RR. Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974;134:219-223.
2. Lewis JH, Zimmerman HJ. Drug-induced liver disease. Med Clin North Am 1989;73:775-792.
3. Døssing M, Andreasen PB. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs. Scand J Gastroenterol 1982;17:205-211.
4. Friis H, Andreasen PB. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee of Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992;232:133-138.
5. Maddrey WC, Boitnott JR. Drug-induced chronic liver disease. Gastroenterology 1977;72:1348-1353.
6. Sharp JR, Ishak KG, Zimmerman HJ. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 1980; 92:14-19.
7. Ransohoff DF, Jacobs G. Terminal hepatic failure following a small dose of sulfametoxazole-trimethoprim. Gastroenterology 1981;80:816-819.
8. Shearman DJC, Finlayson NDC. Drugs, toxins, and the liver. In: Diseases of the Gastrointestinal Tract and Liver. London: Churchill Livingstone, 1989.
9. Davies MH, Harrison RF, Elias E, Hubscher G. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994;20:112-116.
10. Calmus Y, Biour M, Poupon R. Les tests in vitro dans le diagnostic des hépatites médicamenteuses. Gastroenterol Clin Biol 1987;11:586-598.
11. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic drug reactions. Ann Intern Med 1986;105:179-183.
12. Gennis MA, Vemmuri R, Burns EA, Hill JV, Miller MA, Spielberg SP. Familial occurrence of hypersensitivity to phenitoin. Am J Med 1991; 91:631-634.
13. Victorino RMM, Maria VAJ. Modifications of lymphocyte transformation test in a case of drug-induced cholestatic hepatitis. Diagnostic Immunol 1985;3:171-181.
14. Victorino RMM, Maria VAJ, Pinto L. Evidence for prostaglandin producing suppressor cells in drug-induced hepatitis and implications in the diagnosis of drug sensitization. Clin Exp Immunol 1992;87:132-137.
15. Maria VAJ, Pinto L, Victorino RMM. Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol 1994;21:151-158.
16. Maria VAJ, Victorino RMM. Lymphocyte proliferation to drugs: Analysis of the value of a 24 well lymphocyte culture system. Toxic in Vitro 1994;8:1041-1044.
17. Tsutsui H, Terano Y, Sakagami C, Haseqawa I, Mizoguchi Y, Morisawa S. Drug specific T cells derived from patients with drug-induced allergic hepatitis. J Immunol 1992;149:706-716.
18. Berg PA, Becker EW. The lymphocyte transformation test a - debated method for the evaluation of drug allergic hepatic injury. J Hepatol 1995;22:115-118.
19. Bénichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990;11:272-276.
20. Danan G, Bénichou C, Flahault A. Score d'imputation d'une atteinte hépatique aigue à un médicament. Gastroenterol Clin Biol 1993;17: H22-24.
21. Danan G. Consensus meeting on causality assessment of drug-induced liver injury. J Hepatol 1988;7:132-136.
22. Steiner DL, Norman GR. Health Measurement Scales. A Practical Guide to Their Development and Use. Oxford: Oxford University Press, 1991.
23. Victorino RMM, Maria VAJ, Correia AP, de Moura MC. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization. Arch Intern Med 1987;147:987-989.
24. Maria VAJ, Silva JP, Victorino RMM. Agranulocytosis and liver damage associated to pyrazinobutazone with evidence for an immunological mechanism. J Rheumatol 1989;16:1484-1485.
25. Stricker BH. Diagnosis and causality assessment of drug-induced hepatic injury. In: Dukes MNG, ed. Drug-Induced Hepatic Injury. Amsterdam: Elsevier, 1992:1-13.
26. Cohen J. Weighted Kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213-220.
27. Landis RJ, Koch GG. The measurement of observer agreement for categorial data. Biometrics 1977;33:159-174.
28. Czaja AJ, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996;41:305-314.